Related Experiment Video
Updated: Nov 27, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Staphylococcal scalded skin syndrome: An epidemiological and clinical review of 84 cases
Carmen Liy-Wong1, Elena Pope1, Miriam Weinstein1
1Division of Pediatric Medicine, Section of Dermatology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Insights
Staphylococcal scalded skin syndrome (SSSS) in children often presents with erythema and exfoliation. Avoid surgical debridement, as it increases complications, and clindamycin shows no benefit in reducing hospitalization for pediatric SSSS.
Area of Science:
- Pediatric Dermatology
- Infectious Diseases
- Clinical Epidemiology
Background:
- Staphylococcal scalded skin syndrome (SSSS) is a toxin-mediated blistering disorder primarily affecting infants and children.
- Limited literature exists on the specific characteristics and management of pediatric SSSS.
- This study aims to detail the epidemiology, clinical presentation, and treatment outcomes of SSSS in a pediatric population.
Purpose of the Study:
- To describe the epidemiology of pediatric Staphylococcal scalded skin syndrome (SSSS).
- To outline the clinical features and common symptoms of SSSS in children.
- To evaluate the management strategies and outcomes for pediatric SSSS cases.
Main Methods:
- A retrospective cohort study was conducted.
- Included pediatric patients with a clinical diagnosis of SSSS from January 1994 to March 2016.
- Data collected on demographics, clinical presentation, microbiology, and treatment outcomes.
Main Results:
- Eighty-four pediatric patients were included, with 58% being male, mean age 3.1 years.
- Erythema and exfoliation were universal; vesicles/bullae occurred in 76%. Skin tenderness was most common (81%).
- Mean hospitalization was 4.7 days; surgical debridement was linked to complications and longer stays. Clindamycin did not alter admission duration.
Conclusions:
- Healthcare providers should consider SSSS in pediatric differential diagnoses for erythema and blistering.
- Periorificial swabs were more likely to yield Staphylococcus aureus, but toxin testing is needed for confirmation.
- Antibiotic choices should be based on sensitivity. Clindamycin's anti-toxin role needs further investigation. Surgical debridement should be avoided.
Background:
Staphylococcal scalded skin syndrome (SSSS) is a toxin-mediated, blistering skin disorder that mainly affects infants and children. There is limited literature regarding pediatric SSSS. The purpose of this study was to describe the epidemiology, clinical features, and management of pediatric SSSS.
Methods:
Retrospective cohort study of pediatric patients with a clinical diagnosis of SSSS seen at the Hospital for Sick Children in Toronto, Ontario, Canada, from January 1994 to March 2016.
Results:
We included 84 patients with a clinical diagnosis of SSSS; 49/84 (58%) were male. Mean age of diagnosis was 3.1 ± 2.4 years. All patients presented with erythema and exfoliation, while 64/84 (76%) presented with vesicles/ bullae. Skin tenderness was the most common symptom, present in 68/84 (81%) subjects. Staphylococcus aureus was more commonly isolated from periorificial cultures than from bullae. Mean hospitalization was 4.7 ± 2.3 days. No difference was found in admission duration between children receiving clindamycin and those that did not (3.6 ± 2.2 vs 3.9 ± 2.34 days, P = .63). Skin debridement was the only risk factor leading to more complications and prolonged hospitalization (P = .03). Severe complications were seen in 4 (5%) cases, and no fatalities were observed.
Conclusions:
Healthcare providers should be aware of SSSS and consider it in the differential diagnosis of infants and children with new onset erythema, exfoliation, and/or vesiculation. Suspected culprit pathogens were more often obtained from periorificial swabs; however, these isolates were not tested for exfoliative toxin to confirm causality. Antibiotic treatment should be guided by sensitivity testing. Addition of clindamycin as an anti-toxin agent had no effect on the duration of hospitalization, and this should be further investigated. Surgical debridement of the skin in patients with SSSS should be discouraged.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

